Takehiro Fukami

3.4k total citations · 1 hit paper
52 papers, 2.4k citations indexed

About

Takehiro Fukami is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, Takehiro Fukami has authored 52 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cellular and Molecular Neuroscience, 34 papers in Molecular Biology and 22 papers in Endocrine and Autonomic Systems. Recurrent topics in Takehiro Fukami's work include Neuropeptides and Animal Physiology (34 papers), Receptor Mechanisms and Signaling (31 papers) and Regulation of Appetite and Obesity (21 papers). Takehiro Fukami is often cited by papers focused on Neuropeptides and Animal Physiology (34 papers), Receptor Mechanisms and Signaling (31 papers) and Regulation of Appetite and Obesity (21 papers). Takehiro Fukami collaborates with scholars based in Japan, United States and United Kingdom. Takehiro Fukami's co-authors include Masaki Ihara, Takahiro Fukuroda, Mitsuo Yano, Toshihiko Saeki, Akio Kanatani, Masaru Nishikibe, Kazuhito Noguchi, Sonoko Tsuchida, Akane Ishihara and Hisashi Iwaasa and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

Takehiro Fukami

52 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor

1992 774 citations Masaki Ihara, Kazuhito Noguchi et al. Life Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takehiro Fukami Japan	24	1.1k	1.0k	768	722	470	52	2.4k
Emmanuel Canet France	22	596 0.5×	717 0.7×	379 0.5×	803 1.1×	140 0.3×	44	2.0k
Carlos Forray United States	28	412 0.4×	1.3k 1.3×	1.0k 1.4×	505 0.7×	92 0.2×	67	2.8k
Philippe Schoeffter Switzerland	39	891 0.8×	2.1k 2.1×	2.0k 2.5×	183 0.3×	443 0.9×	80	3.9k
Shoji Katsuki Japan	10	1.6k 1.4×	947 0.9×	421 0.5×	321 0.4×	648 1.4×	22	2.7k
Michael Korth Germany	26	604 0.5×	1.7k 1.7×	615 0.8×	142 0.2×	928 2.0×	50	2.5k
Nariman Panahian United States	20	1.0k 0.9×	1.3k 1.3×	612 0.8×	199 0.3×	234 0.5×	24	3.0k
John G. McCarron United Kingdom	34	894 0.8×	2.2k 2.2×	869 1.1×	131 0.2×	701 1.5×	101	3.2k
I. Mhairi Macrae United Kingdom	23	452 0.4×	557 0.6×	470 0.6×	130 0.2×	185 0.4×	52	2.0k
Jean‐Marie Stutzmann France	27	575 0.5×	927 0.9×	1.3k 1.7×	149 0.2×	101 0.2×	52	2.6k
Michael Russwurm Germany	34	1.7k 1.5×	1.7k 1.7×	348 0.5×	134 0.2×	771 1.6×	74	3.0k

Countries citing papers authored by Takehiro Fukami

Since Specialization

Citations

This map shows the geographic impact of Takehiro Fukami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehiro Fukami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehiro Fukami more than expected).

Fields of papers citing papers by Takehiro Fukami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takehiro Fukami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehiro Fukami. The network helps show where Takehiro Fukami may publish in the future.

Co-authorship network of co-authors of Takehiro Fukami

This figure shows the co-authorship network connecting the top 25 collaborators of Takehiro Fukami. A scholar is included among the top collaborators of Takehiro Fukami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takehiro Fukami. Takehiro Fukami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takahashi, Toshiyuki, Yuji Haga, Toshihiro Sakamoto, et al.. (2009). Aryl urea derivatives of spiropiperidines as NPY Y5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(13). 3511–3516. 13 indexed citations

Moriya, Ryuichi, Satoshi Mashiko, Akane Ishihara, et al.. (2009). Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice. Peptides. 30(7). 1318–1322. 15 indexed citations

Mashiko, Satoshi, Ryuichi Moriya, Akane Ishihara, et al.. (2009). Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis. European Journal of Pharmacology. 615(1-3). 113–117. 39 indexed citations

Suzuki, Takao, Minoru Moriya, Toshihiro Sakamoto, et al.. (2009). Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(11). 3072–3077. 17 indexed citations

Sakamoto, Toshihiro, Minoru Moriya, Toshiyuki Takahashi, et al.. (2009). Novel orally active NPY Y5 receptor antagonists: Synthesis and structure–activity relationship of spiroindoline class compounds. Bioorganic & Medicinal Chemistry. 17(14). 5015–5026. 10 indexed citations

Moriya, Minoru, Shunji Sakuraba, Toshihiro Sakamoto, et al.. (2009). Identification of 2-aminobenzimidazoles as potent melanin-concentrating hormone 1-receptor (MCH1R) antagonists. Bioorganic & Medicinal Chemistry Letters. 19(13). 3568–3572. 6 indexed citations

Suzuki, Takao, Minoru Kameda, Makoto Ando, et al.. (2009). Discovery of novel diarylketoxime derivatives as selective and orally active melanin-concentrating hormone 1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(18). 5339–5345. 15 indexed citations

Ogino, Yoshio, Norikazu Ohtake, Kenji Matsuda, et al.. (2008). Syntheses and structure–activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1′-cyclohexan]-4′-yl]benzimidazole NPY Y5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(18). 4997–5001. 19 indexed citations

Mashiko, Satoshi, Akane Ishihara, Hisashi Iwaasa, et al.. (2008). Effects of a Novel Y5 Antagonist in Obese Mice: Combination With Food Restriction or Sibutramine. Obesity. 16(7). 1510–1515. 24 indexed citations

10.

Kanatani, Akio, Akane Ishihara, Hisashi Iwaasa, Douglas J. MacNeil, & Takehiro Fukami. (2006). . Folia Pharmacologica Japonica. 127(2). 88–91. 2 indexed citations

11.

Fukami, Takehiro, Hiroyuki Takahashi, Toshihiro Sakamoto, et al.. (2005). Convenient synthesis of 2-alkylamino-6-carboxy-5,7-diarylcyclopenteno[1,2-b]pyridines via direct acylamination with imidoyl chlorides. Tetrahedron. 61(14). 3473–3481. 5 indexed citations

12.

Mashiko, Satoshi, Akane Ishihara, Hisashi Iwaasa, et al.. (2003). Characterization of Neuropeptide Y (NPY) Y5 Receptor-Mediated Obesity in Mice: Chronic Intracerebroventricular Infusion ofd-Trp³⁴NPY. Endocrinology. 144(5). 1793–1801. 51 indexed citations

13.

Hirose, Masaaki, Shinichiro Egashira, Yasuhiro Gotô, et al.. (2003). N- Acyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline: The first orexin-2 receptor selective non-peptidic antagonist. Bioorganic & Medicinal Chemistry Letters. 13(24). 4497–4499. 84 indexed citations

14.

Ohe, Tomoyuki, Masahiko Sato, Sachiko Tanaka, et al.. (2003). EFFECT OF P-GLYCOPROTEIN-MEDIATED EFFLUX ON CEREBROSPINAL FLUID/PLASMA CONCENTRATION RATIO. Drug Metabolism and Disposition. 31(10). 1251–1254. 36 indexed citations

15.

Kanatani, Akio, Akane Ishihara, Hisashi Iwaasa, et al.. (2000). L-152,804: Orally Active and Selective Neuropeptide Y Y5 Receptor Antagonist. Biochemical and Biophysical Research Communications. 272(1). 169–173. 110 indexed citations

16.

Kanatani, Akio, Tetsuya Kanno, Akane Ishihara, et al.. (1999). The Novel Neuropeptide Y Y1 Receptor Antagonist J-104870: A Potent Feeding Suppressant with Oral Bioavailability. Biochemical and Biophysical Research Communications. 266(1). 88–91. 72 indexed citations

17.

Ishikawa, Kiyofumi, Takehiro Fukami, Toshiaki Mase, et al.. (1995). Endothelin Receptor Antagonists with Various Subtype-Specificity: Their Discovery and Use as Pharmacological Tools. European Journal of Medicinal Chemistry. 30. 371s–383s. 3 indexed citations

18.

Fukami, Takehiro, Kagari Fujita, Takashi Hayama, et al.. (1995). Structure-Activity Relationships of Cyclic Pentapeptide Endothelin A Receptor Antagonists. Journal of Medicinal Chemistry. 38(21). 4309–4324. 29 indexed citations

19.

Ihara, Masaki, Kenji Ohwaki, Satoshi Ozaki, et al.. (1995). [3H]BQ-123, a highly specific and reversible radioligand for the endothelin ETA receptor subtype. European Journal of Pharmacology. 274(1-3). 1–6. 32 indexed citations

20.

Ihara, Masaki, Kazuhito Noguchi, Toshihiko Saeki, et al.. (1992). Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sciences. 50(4). 247–255. 774 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact